Aziyo Financial Statements From 2010 to 2024

AZYODelisted Stock  USD 2.44  0.00  0.00%   
Aziyo Biologics financial statements provide useful quarterly and yearly information to potential Aziyo Biologics investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aziyo Biologics financial statements helps investors assess Aziyo Biologics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Aziyo Biologics' valuation are summarized below:
Aziyo Biologics does not presently have any fundamental signals for analysis.
Check Aziyo Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aziyo Biologics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Aziyo financial statements analysis is a perfect complement when working with Aziyo Biologics Valuation or Volatility modules.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Aziyo Biologics Company Current Valuation Analysis

Aziyo Biologics' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Aziyo Biologics Current Valuation

    
  40.69 M  
Most of Aziyo Biologics' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aziyo Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Aziyo Biologics has a Current Valuation of 40.69 M. This is 99.72% lower than that of the Health Care Equipment & Supplies sector and 99.67% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.76% higher than that of the company.

Aziyo Biologics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aziyo Biologics's current stock value. Our valuation model uses many indicators to compare Aziyo Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aziyo Biologics competition to find correlations between indicators driving Aziyo Biologics's intrinsic value. More Info.
Aziyo Biologics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aziyo Biologics' earnings, one of the primary drivers of an investment's value.

About Aziyo Biologics Financial Statements

Aziyo Biologics investors utilize fundamental indicators, such as revenue or net income, to predict how Aziyo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic devicecardiovascular, orthopedicspinal repair, and soft tissue reconstruction markets. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland. Aziyo Biologics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 162 people.

Pair Trading with Aziyo Biologics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aziyo Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aziyo Biologics will appreciate offsetting losses from the drop in the long position's value.

Moving against Aziyo Stock

  0.68EC Ecopetrol SA ADRPairCorr
  0.61SHG Shinhan FinancialPairCorr
  0.59BA Boeing Fiscal Year End 29th of January 2025 PairCorr
  0.49MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.46WF Woori Financial GroupPairCorr
The ability to find closely correlated positions to Aziyo Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aziyo Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aziyo Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aziyo Biologics to buy it.
The correlation of Aziyo Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aziyo Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aziyo Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aziyo Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in Aziyo Stock

If you are still planning to invest in Aziyo Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo Biologics' history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope